Adefovir-associated HIV-1 RT mutation K70E in the age of tenofovir

被引：0
|
作者：
Kagan, R
Ross, L
Winters, M
Merigan, T
Heseltine, P
Lewinski, M
机构：
[1] Quest Diagnost Nichols Inst, San Juan Capistrano, CA USA
[2] GlaxoSmithKline Inc, Res Triangle Pk, NC USA
[3] Stanford Univ, Ctr AID Res, Stanford, CA 94305 USA
来源：
ANTIVIRAL THERAPY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [1] Adefovir-associated HIV-1 RT mutation K70E in the age of tenofovir
    Kagan, R
    Ross, L
    Winters, M
    Merigan, T
    Heseltine, P
    Lewinski, M
    ANTIVIRAL THERAPY, 2005, 10 (04) : S103 - S103
  • [2] NRTI resistance associated with the RT mutation K70E in HIV-1
    Van Houtte, M.
    Staes, M.
    Geretti, A. M.
    Pattery, T.
    Bacheler, L.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S160 - S160
  • [3] Relative fitness and tenofovir resistance levels of K70E and K65R HIV-1 RT mutants favours selection of K65R over K70E viruses in the presence of tenofovir
    Svarovskaia, E. S.
    Goodman, D.
    Ly, J.
    Eastoak-Siletz, A.
    White, K.
    LaFlamme, G.
    Margot, N. A.
    Miller, M. D.
    Borroto-Esoda, K.
    ANTIVIRAL THERAPY, 2007, 12 : S110 - S110
  • [4] Relative fitness and tenofovir resistance levels of K70E and K65R HIV-1 RT mutants favours selection of K65R over K70E viruses in the presence of tenofovir
    Svaropskaia, E. S.
    Goodman, D.
    Ly, J.
    Eastoak-Siletz, A.
    White, K.
    LaFlamme, G.
    Margot, N. A.
    Miller, M. D.
    Borroto-Esoda, K.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S110 - S110
  • [5] National survey of the prevalence and conditions of selection of HIV-1 reverse transcriptase K70E mutation
    Delaugerre, C.
    Flandre, P.
    Marcelin, A. G.
    Descamps, D.
    Tamalet, C.
    Cottalorda, J.
    Schneider, V.
    Yerly, S.
    LeGoff, J.
    Joubert, L. Morand
    Chaix, M. L.
    Costagliola, D.
    Calvez, V.
    JOURNAL OF MEDICAL VIROLOGY, 2008, 80 (05) : 762 - 765
  • [6] Molecular basis of antagonism between K70E and K65R tenofovir-associated mutations in HIV-1 reverse transcriptase
    Kagan, R. M.
    Lee, T.-S.
    Ross, L.
    Lloyd, R. M., Jr.
    Lewinski, M. A.
    Potts, S. J.
    ANTIVIRAL RESEARCH, 2007, 75 (03) : 210 - 218
  • [7] Selection of the HIV-1 reverse transcriptase mutation K70E in antiretroviral-naive subjects treated with tenfovir/abacavir/lamivudine therapy
    Ross, L
    Gerondelis, P
    Liao, Q
    Wine, B
    Lim, M
    Shaefer, M
    Rodríguez, A
    Limoli, K
    Huang, W
    Parkin, NT
    Gallant, J
    Lanier, R
    ANTIVIRAL THERAPY, 2005, 10 (04) : S102 - S102
  • [8] Selection of the HIV-1 reverse transcriptase mutation K70E in antiretroviral-naive subjects treated with tenfovir/abacavir/lamivudine therapy
    Ross, L
    Gerondelis, P
    Liao, Q
    Wine, B
    Lim, M
    Shaefer, M
    Rodriguez, A
    Limoli, K
    Huang, W
    Parkin, NT
    Gallant, J
    Lanier, R
    ANTIVIRAL THERAPY, 2005, 10 : S102 - S102
  • [9] HIV-1 reverse transcriptase (RT) genotypic patterns and treatment characteristics associated with the K65R RT mutation
    Boucher, S.
    Recordon-Pinson, P.
    Ragnaud, J. M.
    Dupon, M.
    Fleury, H.
    Masquelier, B.
    HIV MEDICINE, 2006, 7 (05) : 294 - 298
  • [10] Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection
    Koen KA Van Rompay
    Jeffrey A Johnson
    Emily J Blackwood
    Raman P Singh
    Jonathan Lipscomb
    Timothy B Matthews
    Marta L Marthas
    Niels C Pedersen
    Norbert Bischofberger
    Walid Heneine
    Thomas W North
    Retrovirology, 4
12345